Trajenta®
linagliptin
About Trajenta®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults, used in monotherapy (if metformin is not tolerated or contraindicated) or in combination therapy.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Type 2 diabetes mellitus
Brand Names
Trajenta® Tradjenta® Trazenta® Trayenta®
Active ingredients
linagliptin